Cardiol Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 24 Jun 24 | BuyUS$101,439 | David Elsley | Individual | 50,000 | US$2.03 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 15,005 | 0.0188% |
| Individual Insiders | 3,694,104 | 4.62% |
| Institutions | 5,194,070 | 6.5% |
| General Public | 70,996,910 | 88.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.5%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1,771,270 | US$2.9m | 2.85% | 1.34% | |||
| 1,204,500 | US$2.0m | 0% | no data | |||
| 1,170,869 | US$1.9m | -20.2% | 0.34% | |||
| 851,580 | US$1.4m | 10.4% | no data | |||
| 795,625 | US$1.3m | -13.9% | 0.11% | |||
| 467,290 | US$771.7k | 0% | no data | |||
| 447,713 | US$739.3k | 42.4% | no data | |||
| 273,281 | US$451.3k | 7.9% | 0.15% | |||
| 220,521 | US$364.2k | 44.7% | no data | |||
| 161,950 | US$267.4k | 237% | 0.01% | |||
| 142,500 | US$235.3k | 0% | no data | |||
| 120,000 | US$198.2k | 100% | no data | |||
| 110,000 | US$181.6k | 0% | no data | |||
| 100,000 | US$165.1k | 0% | 0.09% | |||
| 100,000 | US$165.1k | 0% | no data | |||
| 100,000 | US$165.1k | 0% | 0.01% | |||
| 80,000 | US$132.1k | 0% | no data | |||
| 63,700 | US$105.2k | 133% | no data | |||
| 61,001 | US$100.7k | -47.5% | no data | |||
| 57,650 | US$95.2k | 0.26% | no data | |||
| 55,000 | US$90.8k | 0% | 0.03% | |||
| 52,435 | US$86.6k | 0% | no data | |||
| 50,000 | US$82.6k | -0.22% | no data | |||
| 36,900 | US$60.9k | 0% | 0.01% | |||
| 36,100 | US$59.6k | 53.6% | no data |